2011
DOI: 10.1016/j.bjps.2010.05.033
|View full text |Cite
|
Sign up to set email alerts
|

Surgical management of arteriovenous malformation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
57
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 81 publications
(59 citation statements)
references
References 11 publications
0
57
0
Order By: Relevance
“…It seems that postponing the arteriovenous malformation surgery in patients who reveal the symptoms of growth is not justified (16). A delay in making the decision may only lead to an increased probability of developing infection, necrosis or bleeding within the tumour and definitely hampers the procedure itself.…”
Section: Discussionmentioning
confidence: 99%
“…It seems that postponing the arteriovenous malformation surgery in patients who reveal the symptoms of growth is not justified (16). A delay in making the decision may only lead to an increased probability of developing infection, necrosis or bleeding within the tumour and definitely hampers the procedure itself.…”
Section: Discussionmentioning
confidence: 99%
“…Clinically, arteriovenous malformations can appear in soft tissues or bone and are typically not accompanied by pain, but rather frequent episodes of bleeding. These lesions have a reliable natural history comprised of four distinct stages: quiescent, growing, symptomatic, and decompensating (Lee et al 2004, Visser et al 2011 Presenting symptoms include congestive heart failure, embolism, pain, bleeding, and ulceration (Joshua et al 2014). On physical examination, the lesions may appear blue and may feel warm with pulsating and thrill because of the increased blood flow.…”
Section: Discussionmentioning
confidence: 99%
“…The Schobinger staging system of arteriovenous malformations includes four grades of severity: dormancy, expansion, destruction and decompensation (Visser et al 2011).…”
Section: Discussionmentioning
confidence: 99%
“…The intriguing data of Boye and colleagues suggest one mechanism for hemangioma formation and bring the field a step closer to understanding the molecular etiology of this common tumor. (17), (37) Newer treatment options for hemangioma may well pose less risk for the patient, allowing the practitioner to intervene in a relatively safe, and more timely manner. Propranolol is now first-line therapy for many practitioners, and it is hoped that future studies will confirm its efficacy and safety.…”
Section: Pathophysiology:-mentioning
confidence: 99%